Key Takeaways BPC-157 reduces inflammation markers by up to 60% and may help repair damaged reproductive tissue TB-500 shows promise in reducing endometrial adhesions and fibrosis formation Peptide therapy targets root inflammatory causes rather than just masking pain symptoms Clinical evidence suggests 40-50% pain reduction when peptides are used with conventional treatment Medical supervision is essential as peptide therapy for endometriosis remains investigational in 2026 Understanding Endometriosis and Inflammation Endometriosis affects approximately 10% of reproductive-age women and creates chronic inflammation throughout the pelvic cavity
The Verdict: For weight loss and metabolic correction, GLP-1 agonists are the clinically validated choice
In testes, it improves microcirculation, reduces oxidative stress, and aids tissue recovery
Instead, reducing high-impact activities like running while maintaining low-impact exercise such as swimming or cycling provides the best balance
BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid pentadecapeptide derived from a partial sequence of a protein originally identified in human gastric juice
Additionally, some individuals taking Mounjaro may have pre-existing conditions that independently increase their risk of B12 deficiency, such as previous bariatric surgery or concurrent metformin use (the MHRA has highlighted that metformin can reduce vitamin B12 levels)